Physician profile
Richard Pecunia
NPI 1205944659
$7,081.65
in general payments reported to CMS, 2019-2025
22 companies · $1,459 in 2025
The $1,459 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $316 · 2021: $407 · 2022: $660 · 2023: $2,888 · 2024: $853 · 2025: $1,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,465 · Travel and Lodging: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,465.10 |
| Travel and Lodging | $1,735.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,329.32 | 2023-2025 | |
| Allergan, INC. | $1,356.02 | 2019-2022 | |
| Motiva USA, LLC | $577.67 | 2024-2025 | |
| Revance Therapeutics, INC. | $482.46 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $255.13 | 2019-2025 | Dysport |
| Merz North America, INC. | $216.61 | 2019-2025 | |
| Integra Lifesciences Corporation | $148.38 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sientra, INC. | $126.61 | 2020-2021 | |
| Mentor Worldwide LLC | $122.73 | 2023-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $109.82 | 2023 | Phasix Mesh |
| Medela LLC | $70.35 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $58.83 | 2023 | |
| Ethicon US, LLC | $40.00 | 2024 | Dermabond Prineo, Stratafix |
| Hologic Sales and Service, LLC | $35.69 | 2023-2025 | Novasure, Myosure Tissue Removal Device |
| Acacia Pharma INC | $32.46 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.16 | 2020 | |
| Kerecis Limited | $19.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $16.69 | 2020 | |
| Acera Surgical, INC. | $15.95 | 2019 | |
| Endo Pharmaceuticals INC. | $15.93 | 2024 | Xiaflex |
| Baudax Bio INC. | $15.17 | 2021 | |
| Mallinckrodt Hospital Products INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Pecunia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.